Operating Margin of Intellia Therapeutics, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Intellia Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Intellia Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -832%, a 33% increase year-over-year.
  • Intellia Therapeutics, Inc. annual Operating Margin for 2024 was -923%, a 35% increase from 2023.
  • Intellia Therapeutics, Inc. annual Operating Margin for 2023 was -1421%, a 62% decline from 2022.
  • Intellia Therapeutics, Inc. annual Operating Margin for 2022 was -879%, a 8.5% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Intellia Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -832% +416% +33% 01 Jul 2025 30 Sep 2025
Q2 2025 -969% +171% +15% 01 Apr 2025 30 Jun 2025
Q1 2025 -1187% -204% -21% 01 Jan 2025 31 Mar 2025
Q4 2024 -923% +497% +35% 01 Oct 2024 31 Dec 2024
Q3 2024 -1248% -310% -33% 01 Jul 2024 30 Sep 2024
Q2 2024 -1140% -273% -31% 01 Apr 2024 30 Jun 2024
Q1 2024 -983% -187% -23% 01 Jan 2024 31 Mar 2024
Q4 2023 -1421% -541% -62% 01 Oct 2023 31 Dec 2023
Q3 2023 -938% -104% -13% 01 Jul 2023 30 Sep 2023
Q2 2023 -867% +4% +0.46% 01 Apr 2023 30 Jun 2023
Q1 2023 -796% +169% +18% 01 Jan 2023 31 Mar 2023
Q4 2022 -879% -69% -8.5% 01 Oct 2022 31 Dec 2022
Q3 2022 -834% +24% +2.8% 01 Jul 2022 30 Sep 2022
Q2 2022 -871% -426% -96% 01 Apr 2022 30 Jun 2022
Q1 2022 -966% -675% -232% 01 Jan 2022 31 Mar 2022
Q4 2021 -810% -575% -244% 01 Oct 2021 31 Dec 2021
Q3 2021 -858% -659% -331% 01 Jul 2021 30 Sep 2021
Q2 2021 -445% -206% -86% 01 Apr 2021 30 Jun 2021
Q1 2021 -291% -37% -15% 01 Jan 2021 31 Mar 2021
Q4 2020 -236% +11% +4.6% 01 Oct 2020 31 Dec 2020
Q3 2020 -199% +44% +18% 01 Jul 2020 30 Sep 2020
Q2 2020 -239% +22% +8.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -254% +23% +8.2% 01 Jan 2020 31 Mar 2020
Q4 2019 -247% +52% +17% 01 Oct 2019 31 Dec 2019
Q3 2019 -243% +81% +25% 01 Jul 2019 30 Sep 2019
Q2 2019 -261% +36% +12% 01 Apr 2019 30 Jun 2019
Q1 2019 -276% +13% +4.3% 01 Jan 2019 31 Mar 2019
Q4 2018 -299% -32% -12% 01 Oct 2018 31 Dec 2018
Q3 2018 -325% 01 Jul 2018 30 Sep 2018
Q2 2018 -297% 01 Apr 2018 30 Jun 2018
Q1 2018 -289% 01 Jan 2018 31 Mar 2018
Q4 2017 -266% 01 Oct 2017 31 Dec 2017

Intellia Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -923% +497% +35% 01 Jan 2024 31 Dec 2024
2023 -1421% -541% -62% 01 Jan 2023 31 Dec 2023
2022 -879% -69% -8.5% 01 Jan 2022 31 Dec 2022
2021 -810% -575% -244% 01 Jan 2021 31 Dec 2021
2020 -236% +11% +4.6% 01 Jan 2020 31 Dec 2020
2019 -247% +52% +17% 01 Jan 2019 31 Dec 2019
2018 -299% -32% -12% 01 Jan 2018 31 Dec 2018
2017 -266% -71% -36% 01 Jan 2017 31 Dec 2017
2016 -195% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.